Market Overview

US Stock Futures Edge Higher; All Eyes On Fed

US Stock Futures Edge Higher; All Eyes On Fed
Related BDX
BD MAX™ Enteric Parasite Panel Receives FDA Clearance for Detection of Common and Pathogenic Intestinal Parasites
Barron's Recap: Time To Buy Commodities
A New Leader For The Medtech Industry Thanks To Mega M&A (Seeking Alpha)
Related AZN
AstraZeneca to Present Data Demonstrating Diversity of Its Portfolio of Innovative Formulations and Devices at the European Respiratory Society International Congress 2015
Biotechs Coming Off One Of The Busiest Weeks In Recent Memory
Bristol-Myers to Pay $14M to Settle China Bribe Charges (Zacks)

Pre-open movers

US stock futures rose in early pre-market trade, ahead of the policy decision from the Federal Reserve. Data on housing starts for August will be released at 8:30 a.m. ET, while the Federal Open Market Committee will announce its policy decision and economic projections at 2:00 p.m. ET. Futures for the Dow Jones Industrial Average surged 13 points to 15,478.00, while the Standard & Poor's 500 index futures rose 1.90 points to 1,700.20. Futures for the Nasdaq 100 index gained 9 points to 3,193.00.

A Peek Into Global Markets

European markets were higher today, with the Spanish Ibex Index gaining 0.51%, London's FTSE 100 index rising 0.17% and STOXX Europe 600 Index surging 0.47%. German DAX 30 index gained 0.50% and French CAC 40 Index rose 0.51%.

Asian markets ended mostly higher today. Japan's Nikkei Stock Average surged 1.35%, while China's Shanghai Composite rose 0.29%. Australia's ASX/S&P500 dropped 0.28%, Hong Kong's Hang Seng Index declined 0.27% and India's Sensex jumped 0.8%.

Broker Recommendation

Analysts at Piper Jaffray upgraded Becton, Dickinson and Company (NYSE: BDX) from “neutral” to “overweight.” The target price for Becton, Dickinson and Company has been raised from $91 to $117.

Becton, Dickinson's shares closed at $100.80 yesterday.

Breaking news

  • AstraZeneca (NYSE: AZN) today announced that the US Food and Drug Administration (FDA) has accepted for review a New Drug Application (NDA) for EpanovaTM, an investigational compound for the treatment for patients with severe hypertriglyceridaemia (triglyceride levels greater than or equal to 500mg/dL). To read the full news, click here.
  • (NASDAQ: SOHU) announced today that its majority-owned search subsidiary Sogou, has paid to the holders of Series A Preferred Shares of Sogou a special dividend in the aggregate amount of $300,892,698. To read the full news, click here.
  • Visage Mobile, Inc., the SaaS enterprise mobility management (EMM) solution, today announced a strategic investment by Concur (NASDAQ: CNQR), the global leader in integrated travel and expense management, through the Concur Perfect Trip™ Fund. To read the full news, click here.
  • BlackBerry (NASDAQ: BBRY) today introduced the new BlackBerry(R) Z30 smartphone, BlackBerry's biggest, fastest and most advanced smartphone. Featuring BlackBerry(R) 10 OS version 10.2, the new all-touch BlackBerry Z30 smartphone comes with a beautiful 5" display and the largest battery yet on a BlackBerry smartphone. To read the full news, click here.

Posted-In: Piper Jaffray US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets


Related Articles (AZN + BBRY)

Get Benzinga's Newsletters